About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology
›
top-articles
Department of Hematology
126
(top 1%)
papers
3.1K
(top 1%)
citations
30
(top 1%)
h
-index
55
(top 1%)
g
-index
129
all documents
3.4K
doc citations
970
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Cancer Discovery
2016
372
2
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
Nature Genetics
2016
231
3
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Leukemia
2020
198
4
Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease
Blood
2014
197
5
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
Nature Medicine
2016
195
6
Pathogenesis and management of iron toxicity in thalassemia
Annals of the New York Academy of Sciences
2010
125
7
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
Nature Medicine
2021
118
8
Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes
Transfusion
2015
107
9
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Blood Advances
2019
89
10
Enhancer Hijacking Drives Oncogenic
BCL11B
Expression in Lineage-Ambiguous Stem Cell Leukemia
Cancer Discovery
2021
83
11
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
2019
77
12
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia
Blood Advances
2019
71
13
Objectives and Mechanism of Iron Chelation Therapy
Annals of the New York Academy of Sciences
2005
68
14
Survival following allogeneic transplant in patients with myelofibrosis
Blood Advances
2020
63
15
Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study
American Journal of Hematology
2013
59
16
Severe and persistent heparin‐induced thrombocytopenia despite fondaparinux treatment
American Journal of Hematology
2015
59
17
Molecular classification improves risk assessment in adult
BCR-ABL1–
negative B-ALL
Blood
2021
59
18
Inhaled medicinal cannabis and the immunocompromised patient
Supportive Care in Cancer
2015
54
19
Mechanism of Iron Toxicity
Food and Nutrition Bulletin
2007
47
20
Autologous transplant remains the preferred therapy for relapsed APL in CR2
Bone Marrow Transplantation
2016
46
21
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis
Cancer
2016
45
22
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Biology of Blood and Marrow Transplantation
2017
41
23
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129
Leukemia Research
2013
40
24
Single-agent dabrafenib for
BRAF
V600E
-mutated histiocytosis
Haematologica
2018
40
25
Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma
Biology of Blood and Marrow Transplantation
2015
39
26
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
Current Oncology Reports
2016
38
27
Geography, ethnicity and “roots” in chronic lymphocytic leukemia
Leukemia and Lymphoma
2013
37
28
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Blood Advances
2018
35
29
Iron loading and its clinical implications
American Journal of Hematology
2007
33
30
Iron Deficiency, <i>Helicobacter</i> Infection and Gastritis
Acta Haematologica
2009
31
31
High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome
Leukemia
2014
30
32
Venetoclax is safe and efficacious in relapsed/refractory AML
Leukemia and Lymphoma
2020
30
33
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis
Leukemia Research
2013
29
34
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series
BMC Medicine
2014
29
35
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
Genes Chromosomes and Cancer
2016
28
36
North American Leukemia, Intergroup Phase III Randomized Trial of Single Agent Clofarabine As Induction and Post-Remission Therapy, and Decitabine As Maintenance Therapy in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age ≥60 Years): A Trial of the ECOG-ACRIN Cancer Research Group (E2906)
Blood
2015
28
37
Iron chelation therapy
Psychophysiology
2005
28
38
Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia
Haematologica
2018
26
39
The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study
Leukemia and Lymphoma
2019
24
40
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia
American Journal of Hematology
2015
22
41
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria
Clinical Lymphoma, Myeloma and Leukemia
2016
22
42
Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B‐cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia
Pediatric Blood and Cancer
2019
22
43
Familial hemophagocytic lymphohistiocytosis in Israel: II. Pathologic findings
Cancer
1984
21
44
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease
American Journal of Hematology
2019
21
45
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Biology of Blood and Marrow Transplantation
2020
21
46
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
American Journal of Hematology
2021
20
47
Higher Infection Rate After 7- Compared With 5-Day Cycle of Azacitidine in Patients With Higher-Risk Myelodysplastic Syndrome
Clinical Lymphoma, Myeloma and Leukemia
2015
18
48
Perspectives on current survival and new developments in AML
Best Practice and Research in Clinical Haematology
2021
15
49
Acute lymphoblastic leukemia displays a distinct highly methylated genome
Nature Cancer
2022
15
50
Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome
Leukemia Research
2018
14
site/software ©
exaly
; All materials licenced under
CC by-SA
.